Fundraising FoxSequoia Sciences
Saint Louis, US · Delaware corporation · 2 known investors
Find your way into Sequoia Sciences
Sign up to see every warm intro you have to Sequoia Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sequoia Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sequoia Sciences is a biotechnology company developing vaccines, including a vaccine to prevent recurrent urinary tract infections, with programs spanning clinical development, regulatory strategy, and manufacturing. The company works on immune therapies for infectious diseases and cancer.
Founders & leadership
Investors · 2
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$47.7M disclosed across 1 round · 2020
▶$47.7MraisedDec 2020 · 327 investors · OtherRule 506(b)
- MICHAEL J MERTZDirector
- GEORGE PAZDirector
- JOSEPH P. CONRANDirector
- STEVE M NOTESTINEDirector
- JAMES P BICK, JR.Director
- WILLIAM C RUSNACKDirector
- GARY R ELDRIDGE, JR.Executive Officer, Director
- Amount sold
- $47.7M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2009 | $120.6K |
| Department of Agriculture (USDA) | Phase I | 2005 | $80K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2003 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2003 | — |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2001 | $194.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2001 | $170.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Sequoia Sciences do?
- Sequoia Sciences is a biotechnology company developing vaccines, including a vaccine to prevent recurrent urinary tract infections, with programs spanning clinical development, regulatory strategy, and manufacturing. The company works on immune therapies for infectious diseases and cancer.
- Who founded Sequoia Sciences?
- Sequoia Sciences was founded by GARY R ELDRIDGE, JR., Gary Eldridge.
- Who are Sequoia Sciences's investors?
- Sequoia Sciences's investors include Cultivation Capital, Prolog Ventures.
- How much funding has Sequoia Sciences raised?
- Sequoia Sciences has disclosed $47.7M raised across 1 round.
- Where is Sequoia Sciences headquartered?
- Sequoia Sciences is headquartered in Saint Louis, US.